“Alex made seminal contributions to lipoprotein research, initially as a key member of John Gofman’s team whose pioneering work laid out the entire agenda for the field for decades to follow. Notably, in that era Alex led a series of studies identifying dietary effects on lipoproteins that underlie the recommendations for reducing heart disease risk still in place today. Alex went on to discover several key processes in lipoprotein metabolism, focusing particularly on those involving high density lipoproteins (the “good cholesterol”). His studies set a benchmark for originality and rigor that, together with his commitment to training young scientists, have left an enduring imprint on heart disease research.”
Go here to read an obituary that ran in SFGate.